Bio-Techne Community
Create a narrative
WA
Based on Analyst Price Targets
Innovations In Molecular Diagnostics And Decisive Focus On Growth Verticals Promise Revenue Surge Amid Challenges
US$82.55
FV
4.6% undervalued intrinsic discount8.25%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
20 days agoauthor updated this narrative